Viewing Study NCT01652560


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-01-07 @ 5:59 PM
Study NCT ID: NCT01652560
Status: UNKNOWN
Last Update Posted: 2012-07-30
First Post: 2012-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Sponsor: LiNanlin,Ph.D, Chief Physician,Clinical Professor
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module